Sutton Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Sutton Wealth Advisors's GILD Position: Q3 2023 in Review
Sutton Wealth Advisors reduced its Gilead Sciences (GILD) stake by 14% in Q3 2023, selling an estimated $3.85K and leaving 318 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #339.
Sutton Wealth Advisors first reported a position in GILD in Q1 2016 and has held it in 31 quarters since. The position peaked at $215K in Q1 2016. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Sutton Wealth Advisors held 318 shares of Gilead Sciences worth $23.8K as of Q3 2023.
- Sutton Wealth Advisors sold 50 Gilead Sciences shares in Q3 2023, an estimated $3.85K.
- Gilead Sciences made up 0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #339 holding.
- Sutton Wealth Advisors first reported a position in Gilead Sciences in Q1 2016 and has held it in 31 quarters since.
- Sutton Wealth Advisors's Gilead Sciences position peaked at $215K in Q1 2016.
- 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.